Toxins in Drug Discovery and Pharmacology by Steve PeigneurToxins in Drug Discovery and Pharmacology by Steve Peigneur

Toxins in Drug Discovery and Pharmacology

Guest editorSteve Peigneur

Paperback | April 30, 2018

Pricing and Purchase Info


Earn 529 plum® points

Prices and offers may vary in store


In stock online

Ships free on orders over $25

Not available in stores


Venoms from marine and terrestrial animals (cone snails, scorpions, spiders, snakes, centipedes, cnidarian, etc.) can be seen as untapped cocktails of biologically active compounds that are being increasingly recognized as a new emerging source of peptide-based therapeutics. Venomous animals are considered to be specialized predators that have evolved the most sophisticated peptide chemistry and neuropharmacology for their own biological purposes by producing venoms that contain a structural and functional diversity of neurotoxins. These neurotoxins appear to be highly selective ligands for a wide range of ion channels and receptors. Therefore, they represent interesting lead compounds for the development of analgesics, anti-cancer drugs, drugs for neurological disorders such as multiple sclerosis, Parkinson' s disease, Alzheimer' s disease, and other therapeutics.

This Special Issue of Toxins aims to provide a comprehensive look at toxins and toxin-inspired leads and will focus on the mechanisms of action, structure–function relationships, and evolution of pharmacologically interesting venom components, including the most recent developments related to the emergence of venoms as an underutilized source of highly evolved bioactive peptides with clinical potential.

Title:Toxins in Drug Discovery and PharmacologyFormat:PaperbackProduct dimensions:316 pages, 9.61 × 6.69 × 0.86 inShipping dimensions:9.61 × 6.69 × 0.86 inPublished:April 30, 2018Publisher:MDPI AGLanguage:English

The following ISBNs are associated with this title:

ISBN - 10:3038428612

ISBN - 13:9783038428619